Papers

2

Total Citations

88

H-Index

2

About

Zhenbang Liu is a pioneering researcher at the intersection of urologic oncology and advanced materials engineering. His primary research focuses on the clinical management of upper tract urothelial carcinoma (UTUC), a rare but aggressive urologic malignancy, where he has authored influential reviews on optimal multi-modality treatment strategies. His most-cited work, a 2020 comprehensive review on UTUC management (67 citations), critically evaluates the lack of survival improvement over recent decades and advocates for integrated surgical and systemic approaches. Beyond oncology, Liu has made groundbreaking contributions to smart materials, notably developing a self-protective piezoelectric-piezoresistive dual-mode device (2022, 21 citations). This innovation leverages flextensional transduction to achieve superior dynamic-static mechanoresponse and energy harvesting, demonstrating remarkable versatility for wearable sensors and self-powered systems. By bridging clinical urology with cutting-edge materials science, Liu’s work exemplifies translational research—addressing unmet needs in cancer care while advancing next-generation electronic devices. His dual expertise underscores a unique ability to solve complex problems across disciplines, making him a notable figure in both medical and engineering communities.

Research Focus

Key Achievements

2
H-Index
2
Papers
88
Total Citations
44
Avg Citations/Paper
🏆 Most Cited Paper
<p>Optimal Management of Upper Tract Urothelial Carcinoma: Current Perspectives</p>
67 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 15
🏛 Institutions: Nanyang Technological University, Guangzhou University

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago